Related Experiment Video
Updated: Jun 3, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice
Anita M Tuomainen1, Kati Hyvärinen, Pauliina I Ehlers
1Institute of Dentistry, University of Helsinki, FI-00014 Helsinki, Finland.
Background:
Pathogens such as Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn) associate with an increased risk for cardiovascular diseases by inducing inflammation. We hypothesized that the pathogens affect the vascular wall by disturbing cholesterol homeostasis and endothelial function.
Methods:
Aa- and Cpn-infections were induced in apoE-deficient mice by intravenous and intranasal applications, respectively. Cholesterol efflux from mouse peritoneal macrophages to apo(lipoprotein)A-I was assessed. The efflux capacity of mouse sera as acceptors of cholesterol from RAW264.7-macrophages was determined. Additionally, endothelial function was studied by following the relaxation capacity of rat mesenteric arteries after incubation in the conditioned culture media of the peritoneal macrophages isolated from the mice.
Results:
Infection increased serum phospholipid transfer protein (PLTP) and lipopolysaccharide (LPS) activity, as well as serum amyloid A (SAA) and TNF-α concentrations. Peritoneal macrophages of mice with Aa-infection showed increased cholesterol uptake and reduced cholesterol efflux. Sera of Cpn and Cpn + Aa-infected mice had reduced cholesterol efflux capacity from RAW264.7-macrophages. Conditioned macrophage medium from mice with chronic C. pneumoniae infection induced endothelial dysfunction. Additionally, concentrations of serum adhesion molecules, intercellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) in Cpn-groups and E-selectin in Cpn + Aa-group, were elevated. The serum markers of endothelial function correlated positively with SAA.
Conclusions:
Aa- and Cpn-infections may generate proatherogenic changes in the vascular wall by affecting the macrophage cholesterol homeostasis and endothelial function.
Insights
Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn) infections disrupt cholesterol balance and endothelial function, contributing to cardiovascular disease risk. These pathogens promote inflammation and alter macrophage activity, impacting vascular health.
Area of Science:
- Cardiovascular Research
- Infectious Diseases
- Molecular Biology
Background:
- Certain pathogens, including Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn), are linked to increased cardiovascular disease (CVD) risk.
- These infections are known to induce systemic inflammation, a key factor in atherosclerosis development.
Purpose of the Study:
- To investigate the impact of Aa and Cpn infections on cholesterol homeostasis within the vascular wall.
- To determine how these pathogens affect endothelial function and contribute to CVD pathogenesis.
Main Methods:
- Induction of Aa and Cpn infections in apoE-deficient mice.
- Assessment of cholesterol efflux from macrophages and serum cholesterol efflux capacity.
- Evaluation of endothelial function using rat mesenteric arteries and conditioned macrophage media.
Main Results:
- Infections elevated inflammatory markers (SAA, TNF-α) and altered macrophage cholesterol metabolism (increased uptake, reduced efflux).
- Reduced serum cholesterol efflux capacity was observed in Cpn-infected mice.
- Endothelial dysfunction and increased adhesion molecule expression (ICAM, VCAM, E-selectin) were noted, correlating with SAA levels.
Conclusions:
- Aa and Cpn infections induce proatherogenic changes in the vascular wall.
- These changes are mediated by alterations in macrophage cholesterol homeostasis and endothelial function.
- Pathogen-induced inflammation plays a critical role in the development of cardiovascular complications.
More Related Videos
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...

